Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Amgen's Repatha Gets NHS Nod, Sanofi's Praluent Misses Out

This article was originally published in Scrip

Executive Summary

Amgen Inc. looks to be in with a chance to push back its biggest rival, partners Sanofi and Regeneron Pharmaceuticals, and strive for dominance of the PCKS9 market space in the UK for patients with high cholesterol.